NDUFA4
Basic information
Region (hg38): 7:10931943-10940153
Links
Phenotypes
GenCC
Source:
- Leigh syndrome with leukodystrophy (Supportive), mode of inheritance: AR
- Leigh syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex IV deficiency, nuclear type 21 | AR | Biochemical | In addition to other features, individuals have been described as presenting in infancy with lactic acidosis, necessitating treatment with sodium bicarbonate | Biochemical; Musculoskeletal; Neurologic | 23746447 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial complex 4 deficiency, nuclear type 21 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDUFA4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 11 | 12 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 5 | 5 | ||||
non coding | 15 | 25 | ||||
Total | 1 | 2 | 14 | 19 | 9 |
Variants in NDUFA4
This is a list of pathogenic ClinVar variants found in the NDUFA4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-10933655-T-C | not specified | Uncertain significance (Feb 05, 2025) | ||
7-10933663-C-T | Likely benign (Jul 17, 2023) | |||
7-10933664-T-C | Uncertain significance (Apr 30, 2022) | |||
7-10933668-T-C | not specified | Uncertain significance (Jun 02, 2023) | ||
7-10933697-G-A | Likely benign (Oct 10, 2024) | |||
7-10933700-C-A | Likely benign (Oct 19, 2022) | |||
7-10933700-C-G | NDUFA4-related disorder | Likely benign (Nov 27, 2024) | ||
7-10933702-G-C | Likely benign (Oct 24, 2022) | |||
7-10933702-GAA-G | Benign (Dec 21, 2023) | |||
7-10933735-C-T | Benign (Jun 23, 2018) | |||
7-10933742-G-A | Likely benign (Oct 05, 2018) | |||
7-10937809-T-G | Likely benign (Jun 16, 2018) | |||
7-10938003-G-A | Benign (Jun 28, 2018) | |||
7-10938076-A-G | Likely benign (Jul 07, 2023) | |||
7-10938078-T-A | Likely benign (May 22, 2023) | |||
7-10938096-T-C | Likely benign (Feb 04, 2024) | |||
7-10938099-A-G | Likely benign (Jun 21, 2022) | |||
7-10938103-T-C | not specified | Conflicting classifications of pathogenicity (Feb 18, 2025) | ||
7-10938130-G-C | not specified | Uncertain significance (Jan 29, 2025) | ||
7-10938136-T-G | not specified | Uncertain significance (Jul 11, 2023) | ||
7-10938144-C-G | Uncertain significance (Nov 11, 2024) | |||
7-10938263-T-C | Likely benign (Aug 17, 2018) | |||
7-10938647-A-G | Benign (Jun 14, 2018) | |||
7-10938807-C-T | Mitochondrial complex 4 deficiency, nuclear type 21 | Likely pathogenic (Dec 21, 2023) | ||
7-10938830-C-G | Uncertain significance (Mar 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDUFA4 | protein_coding | protein_coding | ENST00000339600 | 4 | 8306 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0239 | 0.788 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00789 | 43 | 43.1 | 0.997 | 0.00000219 | 525 |
Missense in Polyphen | 5 | 6.9676 | 0.7176 | 126 | ||
Synonymous | -0.706 | 19 | 15.5 | 1.23 | 6.87e-7 | 148 |
Loss of Function | 0.967 | 3 | 5.43 | 0.552 | 2.39e-7 | 61 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000881 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytochrome c oxidase (COX, complex IV) is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. Required for complex IV maintenance. {ECO:0000269|PubMed:22902835}.;
- Disease
- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:23746447}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Retrograde endocannabinoid signaling - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Electron Transport Chain;Oxidative phosphorylation;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TP53 Regulates Metabolic Genes;Transcriptional Regulation by TP53;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
(Consensus)
Recessive Scores
- pRec
- 0.230
Intolerance Scores
- loftool
- 0.543
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.662
- hipred
- N
- hipred_score
- 0.267
- ghis
- 0.634
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndufa4
- Phenotype
Gene ontology
- Biological process
- mitochondrial electron transport, NADH to ubiquinone;proton transmembrane transport
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex I;mitochondrial respiratory chain complex IV
- Molecular function
- cytochrome-c oxidase activity;protein binding;NADH dehydrogenase (ubiquinone) activity;protein-containing complex binding